Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response

Giuseppe De Placido, Carlo Alviggi(University of Naples Federico II), Salvatore Conforti(Centro Medicina della Riproduzione), Antonio Mollo(Northwestern University), Ida Strina(University of Naples Federico II), Roberto Clarizia(Ospedale Sacro Cuore Don Calabria)

Fertility and Sterility

January 1, 2006

10.1016/j.fertnstert.2005.07.1280

Cited by 69

Related Papers

The management of Asherman syndrome: a review of literature

|Reproductive Biology and Endocrinology|2013|263

Hysteroscopic resection of the septum improves the pregnancy rate of women with unexplained infertility: a prospective controlled trial

|Fertility and Sterility|2008|247

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial

|Human Reproduction|2004|178

Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study

|Journal of Minimally Invasive Gynecology|2018|150

Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review

|Fertility and Sterility|2018|144